{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:20:17Z","timestamp":1783430417252,"version":"3.54.6"},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["MMW Fortschr Med"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s15006-026-6005-9","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:12:34Z","timestamp":1783429954000},"page":"14-16","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis B\/C und HIV im Check-up 35","Hepatitis B\/C and HIV in the Check-up 35 \u2013 Opportunities, Limitations, and Practical Implementation"],"prefix":"10.1007","volume":"168","author":[{"given":"J\u00f6rg","family":"Schelling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"container-title":["MMW - Fortschritte der Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-026-6005-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15006-026-6005-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-026-6005-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:12:35Z","timestamp":1783429955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.springermedizin.de\/doi\/10.1007\/s15006-026-6005-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":0,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["6005"],"URL":"https:\/\/doi.org\/10.1007\/s15006-026-6005-9","relation":{},"ISSN":["1438-3276","1613-3560"],"issn-type":[{"value":"1438-3276","type":"print"},{"value":"1613-3560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"7 July 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Der Autor erkl\u00e4rt, dass er sich bei der Erstellung des Beitrags von keinen wirtschaftlichen Interessen leiten lie\u00dfen. Er legt folgende potenzielle Interessenkonflikte offen: F\u00fcr diesen Artikel keine. Allgemein: Honorare f\u00fcr Vortr\u00e4ge oder Beratungsleistungen von GSK, MSD, Sanofi, Pfizer, BioNTech, Moderna, Novavax, Takeda, Bavarian Nordic, Viatris, Seqirus, Novartis, Janssen, Kassen\u00e4rztliche Vereinigung Bayern \/ Nordrhein LGL \u2013 LAGI \/ LARE, BL\u00c4K, \u00c4KN, BH\u00c4V und DH\u00c4V.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}